Understand the mechanism.
Examine the evidence.

Femtech Signal examines how women’s health organisations attract attention, build trust, establish partnerships and reach customers. We begin with initiatives discovered in public sources. Organisations enter the archive through that research.

Three distinct layers

Reported activity: what the organisation or another identified source says happened. A company-issued press release remains a company statement, even when a newswire distributes it.

Our interpretation: the commercial mechanism we infer from the available evidence. We label analysis separately from source reporting.

Demonstrated outcomes: measurements with a defined period, population and source. Announcements, reach and distribution agreements do not establish revenue or causal impact.

The atlas draft

The atlas contains 32 records across nine health needs: nine organisations, 14 offerings, four initiatives, three research records and two insights. Offerings have their own source-linked pages and explicit relationships to organisations. The collection was expanded on 29 September 2026. Health-need and life-context tags are editorial classifications; they can overlap and are not clinical recommendations. This is an early, selective collection, not a measure of market size. Each record shows its actual source-review date. A collection update does not imply that every source was checked again.

Research records explicitly distinguish an accessible company summary of a published study from an announced programme. A relationship means only what its label states; it does not imply endorsement or validation of a related product.

Commercial fields and discovery

Commercial fields apply to individual offerings. Markets served are distinct from company headquarters; the buyer, payer and user may be different. A documented field carries its own source and review date. “Not yet researched” means no assessment has been performed; “not found in reviewed source” refers only to the named page. Neither implies the information is unavailable everywhere.

The comparison view filters only source-documented tags. The research desk lists leads separately from published records. Leads pass through assessment, research and editorial review before publication. Source checks are manual; listed priorities do not imply scheduled monitoring.

The original field notes

The original launch edition contains four selected initiatives, researched on 23 September 2026. It is a small initial collection, with US and UK examples and an international product partnership. It is not comprehensive worldwide coverage.

Publication dates, announcement dates and source-check dates serve different purposes. Older initiatives are labelled as archive cases. Where a source does not display an announcement date, we leave it unknown.

How this edition was prepared

Research and analysis were produced with AI assistance from the linked public sources. The source evidence is provided on every initiative page so readers can inspect it directly. No private sales data was used. Automated daily collection and scheduled follow-up are not yet active.

What counts as “working”?

That depends on the objective. Attention, qualified demand, adoption, retention and revenue require different measurements. We do not assign an overall success score or treat absence of disclosed results as failure. Commercial analysis is separate from evaluating clinical effectiveness.

How records can change

New evidence should update the initiative record with a new review date and an explanation of any material correction. The evidence questions on each page identify what would improve the analysis; they do not imply that a follow-up has already occurred.